Using radiotherapy to convert immunologically “cold” tumours into “hot” ones does not enhance the efficacy of checkpoint inhibitors in metastatic non-small cell lung cancer, Australian research shows. No difference in efficacy or toxicity was seen in NSCLC patients who had radiotherapy around the time of starting treatment with anti-PD- 1 immunotherapy compared to patients who ...
Radiotherapy does not alter immunotherapy outcomes in metastatic NSCLC
By Michael Woodhead
19 Aug 2020